Smoking cessation does not alter ST deviation pattern of recurrent myocardial infarctions
International Journal of Cardiology
|March 14, 2007
Summary
Smoking cessation did not change the type of recurrent myocardial infarction (MI). Patients with an initial ST-elevation MI (STEMI) who quit smoking did not alter their risk of subsequent STEMI or non-ST-elevation MI (NSTEMI).
Area of Science:
- Cardiology
- Cardiovascular Medicine
- Public Health
Background:
- Myocardial infarction (MI) is categorized as ST-elevation MI (STEMI) or non-ST-elevation MI (NSTEMI).
- Recurrent MI (RMI) involves distinct coronary sites for each episode.
- Previous research indicated that most RMIs are either STEMI or NSTEMI, not both, and smoking history correlates with recurrent STEMI.
Purpose of the Study:
- To investigate if smoking cessation impacts the type of RMI in patients with an initial STEMI.
- To assess the relationship between smoking status and the classification of recurrent myocardial infarction.
Main Methods:
- Analysis of 128 patients with at least two MI episodes, focusing on native vessels and excluding confounding conditions.
- All participants were active smokers with an index STEMI.
- Patients were categorized into recurrent STEMI (94) or recurrent NSTEMI (34) groups.
Main Results:
- Among patients who ceased smoking before their recurrent MI, 31 (33%) were in the STEMI group and 13 (38%) were in the STE/NSTE group.
- The difference in smoking cessation rates between the recurrent STEMI and recurrent NSTEMI groups was not statistically significant (p=NS).
Conclusions:
- Smoking cessation did not alter the type of recurrent MI in patients who initially presented with STEMI.
- The findings suggest that quitting smoking may not change the specific subtype of subsequent myocardial infarction in this patient population.
Related Concept Videos
Myocarditis IV: Nursing Management
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
Coronary Artery Disease IV: Preventive Measures
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
